Mayors join finance minister to discuss, share feedback on landmark tax

PharmaCare expands diabetes, heart failure, blood clot drugs coverage

January 5, 2023 at 10:14 am  BC, News, Politics, Provincial

Thousands of people in British Columbia will benefit from BC PharmaCare’s expanded coverage of medications used to treat Type 2 diabetes, heart failure and blood clots.

Effective Thursday, Jan. 5, 2023, drug coverage for two medications will be expanded from limited coverage to regular benefit. The two drugs that are becoming regular benefits are dapagliflozin (Forxiga) and apixaban (generics). At the same time, two other medications namely, empagliflozin (Jardiance) and semaglutide (Ozempic), that are covered by PharmaCare under specific medical circumstances will have their limited coverage criteria expanded. This means that more patients will be eligible for coverage of these drugs.

The changes will ensure that coverage is aligned with clinical evidence and will improve patient access to appropriate medications.

Dapagliflozin (Forxiga) is approved by Health Canada to treat several conditions such as heart failure, Type 2 diabetes and chronic kidney disease. It was first listed as a limited coverage benefit on the BC PharmaCare formulary for patients with heart failure with “reduced ejection fraction” on Jan. 11, 2022, a condition where the muscle of the left ventricle is not pumping as well as normal. Currently, approximately 2,000 patients in British Columbia benefit from dapagliflozin under limited coverage. The expansion to a regular benefit is expected to benefit 5,000 more patients in the first year.

Apixaban (generics) is a blood thinner medication used to prevent or treat blood clots. Currently, 45,000 patients in British Columbia benefit from apixaban under limited coverage. The expansion to a regular benefit is projected to benefit approximately 24,000 more patients.

The expansion of limited coverage criteria for empagliflozin (Jardiance) and semaglutide (Ozempic) will make it easier for patients to apply for coverage of these two medications that work to lower blood sugar levels in adults with Type 2 diabetes.

In 2019, PharmaCare provided limited coverage for empagliflozin (Jardiance) and in 2020 limited coverage for semaglutide (Ozempic) to patients with Type 2 diabetes after they had tried and been unable to control their blood sugar levels by taking two other drugs, metformin and a sulfonylurea drug (e.g., glyburide), or metformin and an insulin.

PharmaCare is changing the coverage from third-line to second-line. Patients now only have to try one drug, metformin, before their physician can request coverage of empagliflozin or semaglutide.

Learn More:

To learn more about BC PharmaCare, visit: https://www2.gov.bc.ca/gov/content/health/health-drug-coverage/pharmacare-for-bc-residents

To learn more about the new drug listings, visit:  https://www2.gov.bc.ca/gov/content/health/health-drug-coverage/pharmacare-for-bc-residents/drug-review-process-results/drug-review-decisions

View the full article from the original source

No conversations yet

Activity Stream

Thu, Mar 28, 2024 at 8:00 am - David Suzuki posted on their blog: Climate change, water and ice are inextricably linked
Thu, Mar 21, 2024 at 8:00 am - David Suzuki posted on their blog: Fossil fuel industry gaslighting puts world at risk
Thu, Mar 14, 2024 at 8:00 am - David Suzuki posted on their blog: Alberta adds fuel to the climate crisis fire
Thu, Mar 7, 2024 at 11:30 am - Doug Smith posted on their blog: KamloopsTrails.ca – Kamloops Trails
Thu, Mar 7, 2024 at 8:00 am - David Suzuki posted on their blog: Valuing exponential growth as “progress” is unsustainable
Tue, Mar 5, 2024 at 8:30 am - Doug Smith posted on their blog: Ridge Lakes on Spikes – Kamloops Trails
Mon, Mar 4, 2024 at 2:13 pm - Kamloops Film Society posted on their blog: InfoTel Kamloops horror film festival features all Canadian
Mon, Mar 4, 2024 at 2:11 pm - Kamloops Film Society posted on their blog: Radio NL Mornings with Jeff & Bill – Feb 29, 2024
Full Stream